Article
Loss of BRCA1 protein expression as indicator of the BRCAness phenotype is associated with favorable overall survival after complete resection of sporadic ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Nov 2011
Radosa Marc P, Häfner Norman, Camara Oumar, Diebolder Herbert, Mothes Anke, Winzer Harald, Jansen Lars, Dürst Matthias, Runnebaum Ingo B
Abstract excerpt
OBJECTIVE: Hereditary epithelial ovarian cancers (EOCs) not expressing functional BRCA1 protein are characterized by defects in homologous recombination DNA repair, rendering such tumors more sensitive to DNA damaging agents and synthetic lethality, that is, poly-ADP-ribose-polymerase inhibitor treatment. The aim of this study was to evaluate the use of BRCA1 immunohistochemistry (IHC) for EOC prognosis and...
Topics
- Adenocarcinoma
- Adult
- Aged
- Antineoplastic Agents
- BRCA1 Protein
- Biomarkers, Tumor
- Carboplatin
- Female
- Germany
- Humans
